journal

Impact Factor

 4.5

CiteScore

 8.1

Acceptance rate

 32%

Average time to 1st decision

 12 days

Average Publication Time

 

Publishing options for this journal

$3450

Article Processing Charges (APC), excluding taxes

Subject area
Cardiology, Peripheral Vascular Disease, Pharmacology
Journal scope

Aims & Scope Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research. Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

journal

Impact Factor

 4.1

CiteScore

 8.7

Acceptance rate

 56%

Average time to 1st decision

 14 days

Average Publication Time

 111 days

Publishing options for this journal

$3940

Article Processing Charges (APC), excluding taxes

Subject area
Anti-Infectives and Infectious Diseases, Biochemistry and Molecular Biology, Chemistry, Drug Design & Discovery, Immunology, Inflammation & Allergy, Medicinal Chemistry, Pharmacology
Journal scope

Aims & ScopeCurrent Medicinal Chemistry covers all the latest and outstanding developments in the field of medicinal chemistry. It also includes topics related to quantitative structure-function relationships, drug absorption, drug distribution, drug metabolism, new and emerging drug targets, pharmacogenomics, drug discovery toxicology, high-throughput screening, combinatorial chemistry, structural characterization and organic syntheses of naturally occurring compounds, as well as chemical and analytical techniques used in rational drug design. Each issue incorporates a series of timely in-depth/mini-reviews and guest-edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents.Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be informed and up-to-date with the latest and most important developments relevant to their field.

journal

Impact Factor

 4

CiteScore

 6.7

Acceptance rate

 25%

Average time to 1st decision

 20 days

Average Publication Time

 138 days

Publishing options for this journal

$3745

Article Processing Charges (APC), excluding taxes

Subject area
Biochemical Research Methods, Mathematical & Computational Biology, Life Sciences, Systems Biology & Bioinformatics
Journal scope

Aims & Scope Current Bioinformatics aims to publish all the latest and outstanding developments in bioinformatics. Each issue contains a series of timely, in-depth/mini-reviews, research papers and guest edited thematic issues written by leaders in the field, covering a wide range of the integration of biology with computer and information science. The journal focuses on advances in computational molecular biology, encompassing such niche areas as DNA/RNA/protein sequence alignment and prediction, genes and multi-source heterogeneous networks reconstruction, 3D genome, and spatial transcriptomics computation. The problems belong to the molecules, and the techniques are involved in artificial intelligence and algorithms. Developments in these fields directly affect key issues related to molecular biology, medicine, development of agricultural products, environmental protection, etc. Current Bioinformatics is an essential journal for all academic and industrial researchers who want expert knowledge on all major advances in bioinformatics.

journal

Impact Factor

 3.8

CiteScore

 7.1

Acceptance rate

 24%

Average time to 1st decision

 15 days

Average Publication Time

 100 days

Publishing options for this journal

$3450

Article Processing Charges (APC), excluding taxes

Subject area
Biochemistry and Molecular Biology, Pharmaceutical and Medicinal Chemistry, Pharmacology
Journal scope

Aims & Scope The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.Mini-Reviews in Medicinal Chemistry covers all areas of medicinal chemistry, including quantitative structure-function relationships, synthetic chemistry, bioorganic chemistry, drug absorption, drug distribution, drug metabolism, new and emerging drug targets, pharmacogenomics, drug safety profile and drug-induced liver injury (DILI), drug discovery toxicology, high-throughput screening, combinatorial chemistry, structural characterization and organic syntheses of naturally occurring compounds, "nanosystem and nanocarriers", as well as chemical and analytical techniques used in rational drug design. Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to remain  informed and up-to-date with the latest and most important developments.

journal

Impact Factor

 3.6

CiteScore

 6.9

Acceptance rate

 39%

Average time to 1st decision

 16 days

Average Publication Time

 141 days

Publishing options for this journal

$3633

Article Processing Charges (APC), excluding taxes

Subject area
Genetics & Genomics, Genetics & Heredity, Life Sciences, Molecular Medicine
Journal scope

Aims & Scope Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases. Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.

journal

Impact Factor

 3.4

CiteScore

 6.6

Acceptance rate

 57%

Average time to 1st decision

 18 days

Average Publication Time

 128 days

Publishing options for this journal

$2950

Article Processing Charges (APC), excluding taxes

Subject area
Biochemistry and Molecular Biology, Immunology, Inflammation & Allergy, Pharmaceutical and Medicinal Chemistry, Pharmacology
Journal scope

Aims & Scope Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to in-depth mini-reviews/ research and guest-edited reviews/ research which provide the reader with a comprehensive survey of that respective area. A Guest Editor who is an expert in the topic under review will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. Understanding the relationship between structure and function is crucial to understand the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be informed and up-to-date with the latest and most important advances.

journal

Impact Factor

 3.3

CiteScore

 5.1

Acceptance rate

 55%

Average time to 1st decision

 15 days

Average Publication Time

 99 days

Publishing options for this journal

$1090

Article Processing Charges (APC), excluding taxes

Subject area
Biochemistry and Molecular Biology, Endocrinology, Endocrinology, Medicine, Pharmacology
Journal scope

Aims & Scope Current Diabetes Reviews publishes full-length/mini-reviews, original research articles, drug clinical trial studies, and guest-edited issues on all the latest advances on diabetes and its related areas dedicated to clinical research, e.g., pharmacology, pathogenesis, complications, epidemiology, clinical care, and therapy. It also includes topics related to diabetic complications such as retinopathy, neuropathy, nephropathy, renal failure and impotence, hypertension, gastrointestinal disorders, hearing impairment, hyperlipidemia, vascular and coronary heart diseases. Articles related to pancreatic islet dysfunction and insulin resistance, adipose tissue function, and glucose homeostasis are also covered. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes.

journal

Impact Factor

 3.2

CiteScore

 6.4

Acceptance rate

 24%

Average time to 1st decision

 19 days

Average Publication Time

 142 days

Publishing options for this journal

$2950

Article Processing Charges (APC), excluding taxes

Subject area
Drug Design & Discovery, Pharmacology
Journal scope

Aims & Scope Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

journal

Impact Factor

 3.1

CiteScore

 6.7

Acceptance rate

 37%

Average time to 1st decision

 16 days

Average Publication Time

 120 days

Publishing options for this journal

$3425

Article Processing Charges (APC), excluding taxes

Subject area
Immunology, Inflammation & Allergy, Pharmacology
Journal scope

Aims & Scope Current Pharmaceutical Design publishes timely in-depth reviews/mini reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field. Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

journal

Impact Factor

 3

CiteScore

 5.6

Acceptance rate

 31%

Average time to 1st decision

 16 days

Average Publication Time

 135 days

Publishing options for this journal

$3695

Article Processing Charges (APC), excluding taxes

Subject area
Oncology, Pharmacology
Journal scope

Aims & Scope Current Cancer Drug Targets aims to cover all the latest and outstanding developments in full spectrum of cancer drug discovery and development, including but not limited to cellular and molecular biology, genomics, proteomics, metabolomics, medicinal chemistry, pharmacology, toxicology, and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.Current Cancer Drug Targets publishes original research articles, letters/commentary/perspectives, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer. As the discovery, identification, characterization and validation of novel drug targets for human anticancer drug discovery continues to grow, this journal has become essential reading for all biomedical and pharmaceutical scientists involved in drug discovery and development. Its scope covers publications related to prevention, diagnosis and treatment of all types of human cancers in various of basic and translational researches, including cancer etiology, signal transduction, biomarker, chemotherapy, hormone therapy, gene therapy, immunotherapy, radiotherapy, immunotherapy and combination therapy, stem cell, tumor environment, metabolism emphasizing on advanced mechanistic investigations.

© 2024 Bentham Science Publishers | Privacy Policy